Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX006 Exposure in Knee OA
NCT02003365Phase 2Completed
- Sponsor
- Pacira BioSciences
- Start
- Nov 2013
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in knee osteoarthritis (OA), sponsored by Pacira BioSciences. Started Nov 2013; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02003365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02003365.